IP Roundup: NanoString Technologies, TNO, Roche NimbleGen, Quanterix, HistoRx | GenomeWeb

NanoString Technologies of Seattle has received US Patent No. 8,415,102, "Methods and computer systems for identifying target-specific sequences for use in nanoreporters." The patent relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. The patent also provides methods, computers, and computer program products for identifying target-specific sequences for inclusion in the probes, and methods of making and using such probes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.